Jean‐Michel Germain

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy et al. · New England Journal of Medicine · 2023 · 263 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial

P Boyer, Stuart Montgomery, Ulla Lepola et al. · International Clinical Psychopharmacology · 2008 · 125 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder

L. Septien-Velez, B. Pitrosky, Sudharshan K. Padmanabhan et al. · International Clinical Psychopharmacology · 2007 · 96 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis

J.‐P. Ortonne, C. Paul, Enzo Berardesca et al. · British Journal of Dermatology · 2012 · 93 citations

Medicine, Dermatology, Pharmacology +11

Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept

C.E.M. Griffiths, Wolfram Sterry, F Brock et al. · British Journal of Dermatology · 2014 · 24 citations

Medicine, Dermatology, Pharmacotherapy +11